We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
How to use a cost effectiveness analysis to evaluate your digital health product.
The What Works Network uses evidence to improve the design and delivery of public services.
Data on the real-world efficacy of the COVID-19 vaccines.
Upper Tribunal Administrative Appeals Chamber decision by Judge Wright on 22 August 2024
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
How to use a micro-randomised trial to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).